🇺🇸 FDA
Pipeline program

alprazolam, Placebo matching Staccato® alprazolam and without active substance

EP0165

Phase 3 small_molecule active

Quick answer

alprazolam, Placebo matching Staccato® alprazolam and without active substance for Treatment of stereotypical prolonged seizure is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Treatment of stereotypical prolonged seizure
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials